HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Sprache: Englisch
Verlag: Royal Society of Chemistry, 2019
ISBN 10: 1788014502 ISBN 13: 9781788014502
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 222,99
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Royal Society of Chemistry, 2019
ISBN 10: 1788014502 ISBN 13: 9781788014502
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 233,37
Anzahl: 15 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Sprache: Englisch
Verlag: ROYAL SOCIETY OF CHEMISTRY, 2019
ISBN 10: 1788014502 ISBN 13: 9781788014502
Anbieter: moluna, Greven, Deutschland
Gebunden. Zustand: New. An ideal reference for any student or researcher interested in drug development for neurodegenerative diseases, autoimmune diseases and MS in particular.InhaltsverzeichnisrnrnMultiple Sclerosis: Epidemiology, Genetics, Symptoms, and Unmet Ne.
Sprache: Englisch
Verlag: Royal Society of Chemistry, 2019
ISBN 10: 1788014502 ISBN 13: 9781788014502
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 285,74
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 333 pages. 10.00x6.00x0.50 inches. In Stock.
Buch. Zustand: Neu. Neuware - Multiple sclerosis (MS) is a complex disease with a presumed autoimmune aetiology and few current effective treatments. Disease modifying therapies focus on the altering the natural course of relapsing and remitting MS, targeting the inflammatory response. Other targets involve tacking the cause of the disease - demyelination of axons through remyelination therapies. Due to several recent breakthroughs in the understanding of the pathophysiology of MS new targets for remyelination and immunomodulation are rapidly emerging. This book provides a comprehensive overview of drug discovery and development for the molecular basis of the disease, from new targets to drugs currently in clinical development, cellular and animal disease models to biomarkers for diagnosis and assessment in clinical trials. Emerging Drugs and Targets for Multiple Sclerosis is an ideal reference for any student or researcher interested in drug development for neurodegenerative diseases, autoimmune diseases and MS in particular.